187 related articles for article (PubMed ID: 31634238)
1. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
[TBL] [Abstract][Full Text] [Related]
2. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
4. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
5. [A cohort study of vincristine-induced peripheral neuropathy in children].
Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
[TBL] [Abstract][Full Text] [Related]
7. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
Tunjungsari DA; Gunawan PI; Ugrasena IDG
J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
[TBL] [Abstract][Full Text] [Related]
8. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
10. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
13. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
[TBL] [Abstract][Full Text] [Related]
15. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
Wright GEB; Amstutz U; Drögemöller BI; Shih J; Rassekh SR; Hayden MR; Carleton BC; Ross CJD;
Clin Pharmacol Ther; 2019 Feb; 105(2):402-410. PubMed ID: 29999516
[TBL] [Abstract][Full Text] [Related]
17. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
18. A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy.
Verma P; Devaraj J; Skiles JL; Sajdyk T; Ho RH; Hutchinson R; Wells E; Li L; Renbarger J; Cooper B; Ramkrishna D
Sci Rep; 2020 Jun; 10(1):9659. PubMed ID: 32541868
[TBL] [Abstract][Full Text] [Related]
19. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
